Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/101757
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Rehabilitation Sciences-
dc.creatorLi, Jen_US
dc.creatorCheng, Yen_US
dc.creatorLi, Ren_US
dc.creatorWu, Xen_US
dc.creatorZheng, Cen_US
dc.creatorShiu, PHTen_US
dc.creatorChan, JCKen_US
dc.creatorRangsinth, Pen_US
dc.creatorLiu, Cen_US
dc.creatorLeung, SWSen_US
dc.creatorLee, SMYen_US
dc.creatorZhang, Cen_US
dc.creatorFu, Cen_US
dc.creatorZhang, Jen_US
dc.creatorCheung, TMYen_US
dc.creatorLeung, GPHen_US
dc.date.accessioned2023-09-18T07:44:28Z-
dc.date.available2023-09-18T07:44:28Z-
dc.identifier.issn1942-0900en_US
dc.identifier.urihttp://hdl.handle.net/10397/101757-
dc.language.isoenen_US
dc.publisherHindawi Publishing Corporationen_US
dc.rightsCopyright © 2022 Jingjing Li et al. This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_US
dc.rightsThe following publication Li, J., Cheng, Y., Li, R., Wu, X., Zheng, C., Shiu, P. H. T., ... & Leung, G. P. H. (2022). Protective effects of Amauroderma rugosum on doxorubicin-induced cardiotoxicity through suppressing oxidative stress, mitochondrial dysfunction, apoptosis, and activating Akt/mTOR and Nrf2/HO-1 signaling pathways. Oxidative medicine and cellular longevity, 2022, Article ID 9266178 is available at https://doi.org/10.1155/2022/9266178.en_US
dc.titleProtective effects of amauroderma rugosum on doxorubicin-induced cardiotoxicity through suppressing oxidative stress, mitochondrial dysfunction, apoptosis, and activating Akt/mTOR and Nrf2/HO-1 signaling pathwaysen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.volume2022en_US
dc.identifier.doi10.1155/2022/9266178en_US
dcterms.abstractClinical outcomes for doxorubicin (Dox) are limited by its cardiotoxicity but a combination of Dox and agents with cardioprotective activities is an effective strategy to improve its therapeutic outcome. Natural products provide abundant resources to search for novel cardioprotective agents. Ganoderma lucidum (GL) is the most well-known edible mushroom within the Ganodermataceae family. It is commonly used in traditional Chinese medicine or as a healthcare product. Amauroderma rugosum (AR) is another genus of mushroom from the Ganodermataceae family, but its pharmacological activity and medicinal value have rarely been reported. In the present study, the cardioprotective effects of the AR water extract against Dox-induced cardiotoxicity were studied in vitro and in vivo. Results showed that both the AR and GL extracts could potentiate the anticancer effect of Dox. The AR extract significantly decreased the oxidative stress, mitochondrial dysfunction, and apoptosis seen in Dox-treated H9c2 rat cardiomyocytes. However, knockdown of Nrf2 by siRNA abolished the protective effects of AR in these cells. In addition, Dox upregulated the expression of proapoptotic proteins and downregulated the Akt/mTOR and Nrf2/HO-1 signaling pathways, and these effects could be reversed by the AR extract. Consistently, the AR extract significantly prolonged survival time, reversed weight loss, and reduced cardiac dysfunction in Dox-treated mice. In addition, oxidative stress and apoptosis were suppressed, while Nrf2 and HO-1 expressions were elevated in the heart tissues of Dox-treated mice after treatment with the AR extract. However, the GL extract had less cardioprotective effect against Dox in both the cell and animal models. In conclusion, the AR water extract demonstrated a remarkable cardioprotective effect against Dox-induced cardiotoxicity. One of the possible mechanisms for this effect was the upregulation of the mTOR/Akt and Nrf2/HO-1-dependent pathways, which may reduce oxidative stress, mitochondrial dysfunction, and cardiomyocyte apoptosis. These findings suggested that AR may be beneficial for the heart, especially in patients receiving Dox-based chemotherapy.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationOxidative Medicine and Cellular Longevity, 2022, v. 2022, 9266178en_US
dcterms.isPartOfOxidative medicine and cellular longevityen_US
dcterms.issued2022-
dc.identifier.scopus2-s2.0-85131850906-
dc.identifier.pmid35693699-
dc.identifier.eissn1942-0994en_US
dc.identifier.artn9266178en_US
dc.description.validate202309 bcvc-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumberOA_Scopus/WOS-
dc.description.fundingSourceNot mentionen_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
9266178.pdf4.95 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Page views

128
Last Week
1
Last month
Citations as of Nov 9, 2025

Downloads

39
Citations as of Nov 9, 2025

SCOPUSTM   
Citations

18
Citations as of Dec 19, 2025

WEB OF SCIENCETM
Citations

15
Citations as of Dec 18, 2025

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.